RedHill Biopharma Ltd (RDHL) has released an update.
RedHill Biopharma Ltd. has successfully closed a registered direct offering, raising $1.25 million through the sale of American Depositary Shares and accompanying warrants at a premium price, aimed at bolstering their working capital and supporting general corporate functions. The company is preparing to file its annual report soon and detailed that the offered securities were made available under a previously filed and effective shelf registration statement. No placement agent was involved in the transaction, emphasizing RedHill’s direct engagement with investors.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.
